In addition, ursodeoxycholic acid has been reported that it could inhibit cytokine secretion in ovalbumin sensitive mouse asthma models through farnesoid-X receptors (51), which provides evidence that BA metabolites can mediate the signaling pathway to play a role in lung inflammation. The gene discussed is NR1H4; the disease is asthma.